Application 022134
- Type
- NDA
- Sponsor
- ALLERGAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LASTACAFT | ALCAFTADINE | SOLUTION/DROPS;OPHTHALMIC | 0.25% | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0023-4290 | LASTACAFT | alcaftadine | Allergan, Inc. | NDA | Current |
| 0023-4290 | LASTACAFT | alcaftadine | Allergan, Inc. | NDA | Current |
| 0023-4290 | LASTACAFT | alcaftadine | Allergan, Inc. | NDA | Current |
| 0023-4290 | LASTACAFT | alcaftadine | Allergan, Inc. | NDA | Current |
| 0023-4290 | LASTACAFT | alcaftadine | Allergan, Inc. | NDA | Current |
| 0023-4291 | LASTACAFT | alcaftadine | Allergan, Inc. | NDA | Current |
| 0023-4291 | LASTACAFT | alcaftadine | Allergan, Inc. | NDA | Current |
| 0023-4291 | LASTACAFT | alcaftadine | Allergan, Inc. | NDA | Current |
| 42254-288 | LASTACAFT | alcaftadine | Rebel Distributors Corp | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 71965 | SUPPL | 2022-08-30 |
| 69575 | SUPPL | 2021-12-15 |
| 69540 | SUPPL | 2021-12-13 |
| 63535 | SUPPL | 2020-06-12 |
| 63476 | SUPPL | 2020-06-10 |
| 17001 | SUPPL | 2015-10-07 |
| 6948 | SUPPL | 2015-10-02 |
| 38295 | SUPPL | 2014-12-10 |
| 29305 | SUPPL | 2014-12-05 |
| 24249 | ORIG | 2011-02-17 |
| 21945 | ORIG | 2010-08-23 |
| 38294 | ORIG | 2010-07-31 |
| 29304 | ORIG | 2010-07-30 |
| 53165 | ORIG | 1900-01-01 |
| 53164 | ORIG | 1900-01-01 |
| 53163 | ORIG | 1900-01-01 |